Literature DB >> 6108462

Inactivated vaccine for Ebola virus efficacious in guineapig model.

H W Lupton, R D Lambert, D L Bumgardner, J B Moe, G A Eddy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6108462     DOI： 10.1016/s0140-6736(80)92352-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  26 in total

Review 1.  Emerging targets and novel approaches to Ebola virus prophylaxis and treatment.

Authors:  Jin Huk Choi; Maria A Croyle
Journal:  BioDrugs       Date:  2013-12       Impact factor: 5.807

Review 2.  Ebola Vaccine: How Far are we?

Authors:  Rajani Sharma; Ketki Jangid
Journal:  J Clin Diagn Res       Date:  2017-05-01

Review 3.  Advances in virus-like particle vaccines for filoviruses.

Authors:  Kelly L Warfield; M Javad Aman
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

4.  Establishment and characterization of a lethal mouse model for the Angola strain of Marburg virus.

Authors:  Xiangguo Qiu; Gary Wong; Jonathan Audet; Todd Cutts; Yulian Niu; Stephanie Booth; Gary P Kobinger
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

Review 5.  Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates.

Authors:  John J Suschak; Connie S Schmaljohn
Journal:  Hum Vaccin Immunother       Date:  2019-10-07       Impact factor: 3.452

6.  Generation and characterization of protective antibodies to Marburg virus.

Authors:  Jeffrey W Froude; Thibaut Pelat; Sebastian Miethe; Samantha E Zak; Anna Z Wec; Kartik Chandran; Jennifer Mary Brannan; Russell R Bakken; Michael Hust; Philippe Thullier; John M Dye
Journal:  MAbs       Date:  2017-03-13       Impact factor: 5.857

Review 7.  Current ebola vaccines.

Authors:  Thomas Hoenen; Allison Groseth; Heinz Feldmann
Journal:  Expert Opin Biol Ther       Date:  2012-05-05       Impact factor: 4.388

Review 8.  Ebola vaccines in clinical trial: The promising candidates.

Authors:  Yuxiao Wang; Jingxin Li; Yuemei Hu; Qi Liang; Mingwei Wei; Fengcai Zhu
Journal:  Hum Vaccin Immunother       Date:  2016-10-20       Impact factor: 3.452

9.  Replication-deficient ebolavirus as a vaccine candidate.

Authors:  Peter Halfmann; Hideki Ebihara; Andrea Marzi; Yasuko Hatta; Shinji Watanabe; M Suresh; Gabriele Neumann; Heinz Feldmann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

Review 10.  Ebola virus vaccines: an overview of current approaches.

Authors:  Andrea Marzi; Heinz Feldmann
Journal:  Expert Rev Vaccines       Date:  2014-02-27       Impact factor: 5.217
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.